FirstRanker Logo

FirstRanker.com - FirstRanker's Choice is a hub of Question Papers & Study Materials for B-Tech, B.E, M-Tech, MCA, M.Sc, MBBS, BDS, MBA, B.Sc, Degree, B.Sc Nursing, B-Pharmacy, D-Pharmacy, MD, Medical, Dental, Engineering students. All services of FirstRanker.com are FREE

📱

Get the MBBS Question Bank Android App

Access previous years' papers, solved question papers, notes, and more on the go!

Install From Play Store

Download RGUHS MCh 9164 Urology Paper IV 2019 Dec Question Paper

Download RGUHS (Rajiv Gandhi University of Health Sciences) M.Ch (General Surgery) 2019 December 9164 Urology Paper IV Previous Question Paper

This post was last modified on 16 June 2022

RGUHS M.ch Last 10 Years 2011-2021 Previous Question Papers || Rajiv Gandhi University of Health Sciences


www.FirstRanker.com www.FirstRanker.com

Rajiv Gandhi University of Health Sciences

M.Ch Degree Examination – 18-Dec-2019 Max. Marks: 100 Marks

--- Content provided by FirstRanker.com ---

Time: Three Hours Urology - PAPER – IV

QP Code: 9164

Your answers should be specific to the questions asked.

Draw neat, labeled diagrams wherever necessary. Answer all questions

LONG ESSAY (These questions carry 10 marks each) 10 x 10 = 100 Marks

--- Content provided by‍ FirstRanker.com ---

  1. Describe the different types of bio-materials available for use in urology.
  2. Discuss the applications of molecular biology techniques in Urology.
  3. Discuss techniques for improving efficacy and reducing adverse effects during radiation therapy for prostate cancer.
  4. Discuss recent advances management of Painful Bladder syndrome.
  5. Discuss the effects of radiofrequency energy and its applications in urology.
  6. --- Content provided by⁠ FirstRanker.com ---

  7. Discuss options for managing ureteric obstruction due to extensive pelvic malignancy.
  8. Describe options available for managing radiation cystitis.
  9. Describe the technology behind surgical robots used in urological applications.
  10. Discuss newer bone-protective agents used to reduce fracture risk in urological cancers.
  11. Discuss the rationale for the use of PDE-5 inhibitors for treatment of LUTS due to benign prostatic enlargement.
  12. --- Content provided by​ FirstRanker.com ---

*****

www.FirstRanker.com



--- Content provided by⁠ FirstRanker.com ---

This download link is referred from the post: RGUHS M.ch Last 10 Years 2011-2021 Previous Question Papers || Rajiv Gandhi University of Health Sciences